Regulated information: Disclosure of a transparency notification from BlackRock, Inc.

{
  "signal_id": "bdb291f9-de72-b3fc-eff2-a638440d4a5b",
  "signal_type": "news",
  "signal_subtype": "invests_into",
  "detected_at": "2026-09-29T16:00:00+00:00",
  "company": {
    "name": "BlackRock",
    "domain": "blackrock.com"
  },
  "data": {
    "url": "https://www.globenewswire.com/news-release/2026/09/29/3371169/0/en/regulated-information-disclosure-of-a-transparency-notification-from-blackrock-inc.html",
    "title": "Regulated information: Disclosure of a transparency notification from BlackRock, Inc.",
    "excerpt": "Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 29 September 2026 – 6 PM CET Disclosure of a transparency notification from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of major shareholdings in listed companies, Fagron received a transparency notification from BlackRock, Inc., dated 24 September 2026. Notification from BlackRock, Inc. The total number of 2,119,073 shares corresponds to the same number of voting rights. The total number of 111,702 equivalent financial instruments corresponds to the same number of voting rights. Further information Ignacio Artola Global Head of Investor Relations i***@fagron.com About Fagron Fagron is the leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics, and patients in more than 38 countries around the world. The Belgian company Fagron NV is based in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. Fagron’s operational activities are managed through the Dutch company Fagron BV with head office in Rotterdam. Important information regarding forward-looking statements Certain statements in this press release may be deemed to be forward-looking. Such forward-looking statements are based on current expectations and are influenced by various risks and...",
    "summary": "BlackRock, Inc. has disclosed a major shareholding in Fagron, holding 2,119,073 shares and 111,702 equivalent financial instruments.",
    "location": "Nazareth, Belgium",
    "planning": false,
    "image_url": "https://ml-eu.globenewswire.com/Resource/Download/3973851e-1f98-4337-a6ce-c854d399304c",
    "confidence": 0.9,
    "published_at": "2026-09-29T16:00:00Z",
    "location_data": [
      {
        "city": "Nazareth",
        "state": "East Flanders",
        "region": "Western Europe",
        "country": "Belgium",
        "continent": "Europe",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-09-24",
    "article_sentence": "Pursuant to the Belgian act of 2 May 2007 on the disclosure of major shareholdings in listed companies, Fagron received a transparency notification from BlackRock, Inc., dated 24 September 2026.",
    "financing_type_tags": [
      "equity"
    ],
    "related_company_name": "Fagron",
    "related_company_domain": "fagron.com"
  }
}

curl https://signals.autobound.ai/v1/signals/bdb291f9-de72-b3fc-eff2-a638440d4a5b \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"blackrock.com","limit":20}'